132 related articles for article (PubMed ID: 33178175)
1. Molecular Pap Smear: Validation of HPV Genotype and Host Methylation Profiles of
Shen-Gunther J; Xia Q; Stacey W; Asusta HB
Front Microbiol; 2020; 11():595902. PubMed ID: 33178175
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
[TBL] [Abstract][Full Text] [Related]
3. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.
Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S
PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989
[TBL] [Abstract][Full Text] [Related]
4. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests.
Kahn SL; Ronnett BM; Gravitt PE; Gustafson KS
Cancer; 2008 Feb; 114(1):57-64. PubMed ID: 18181097
[TBL] [Abstract][Full Text] [Related]
5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
6. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
7. Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results.
Liou YL; Zhang Y; Liu Y; Cao L; Qin CZ; Zhang TL; Chang CF; Wang HJ; Lin SY; Chu TY; Zhang Y; Zhou HH
Clin Epigenetics; 2015; 7(1):50. PubMed ID: 25945131
[TBL] [Abstract][Full Text] [Related]
8. Over Expressed TKTL1, CIP-2A, and B-MYB Proteins in Uterine Cervix Epithelium Scrapings as Potential Risk Predictive Biomarkers in HR-HPV-Infected LSIL/ASCUS Patients.
Chiarini A; Liu D; Rassu M; Armato U; Eccher C; Dal Prà I
Front Oncol; 2019; 9():213. PubMed ID: 31001477
[TBL] [Abstract][Full Text] [Related]
9. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
[TBL] [Abstract][Full Text] [Related]
10. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
11. Abundance of HPV L1 Intra-Genotype Variants With Capsid Epitopic Modifications Found Within Low- and High-Grade Pap Smears With Potential Implications for Vaccinology.
Shen-Gunther J; Cai H; Zhang H; Wang Y
Front Genet; 2019; 10():489. PubMed ID: 31231420
[No Abstract] [Full Text] [Related]
12. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 korean women determined by DNA chip.
Hwang HS; Park M; Lee SY; Kwon KH; Pang MG
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2153-6. PubMed ID: 15598774
[TBL] [Abstract][Full Text] [Related]
13. Utility of gene methylation analysis, cytological examination, and HPV-16/18 genotyping in triage of high-risk human papilloma virus-positive women.
Tian Y; Yuan Wu NY; Liou YL; Yeh CT; Cao L; Kang YN; Wang HJ; Li Y; Chu TY; Li W; Liu X; Zhang Y; Zhou H; Zhang Y
Oncotarget; 2017 Sep; 8(37):62274-62285. PubMed ID: 28977944
[TBL] [Abstract][Full Text] [Related]
14. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
15. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
[TBL] [Abstract][Full Text] [Related]
17. Significance of the Cytological Signs of Human Papillomavirus Infection in Anal Pap Smears of Human Immunodeficiency Virus-Infected Japanese Men Who Have Sex with Men.
Okayama K; Okodo M; Kitamura H; Itoda I
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3173-3178. PubMed ID: 29172296
[TBL] [Abstract][Full Text] [Related]
18. HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases.
Liu Q; Zhou X; Zhang X; Strickland AL; Zheng W; Chen H; Zhou F
Cancer Manag Res; 2021; 13():6869-6877. PubMed ID: 34512026
[TBL] [Abstract][Full Text] [Related]
19. HPV-based screening for cervical cancer among women 55-59 years of age.
Bergengren L; Lillsunde-Larsson G; Helenius G; Karlsson MG
PLoS One; 2019; 14(6):e0217108. PubMed ID: 31199811
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
